Survey of management of acquired nystagmus in the United Kingdom

Eye

Volumn 21, Issue 9, 2007, Pages 1194-1197

  Choudhuri, I ^a   Sarvananthan, N ^a,b   Gottlob, I ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; BUSPIRONE; CARBAMAZEPINE; CLONAZEPAM; GABAPENTIN; MEMANTINE; ONDANSETRON; TRIHEXYPHENIDYL;

ARTICLE; CEREBROVASCULAR ACCIDENT; DISEASE SURVEILLANCE; HUMAN; MEDICAL SPECIALIST; MULTIPLE SCLEROSIS; NEUROLOGY; NYSTAGMUS; OPHTHALMIC TECHNOLOGIST; QUESTIONNAIRE; TUMOR; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT; VESTIBULAR DISORDER; VISUAL ACUITY;

EID: 34548539518     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702434     Document Type: Article

References (15)

1. Barton JJS, Huaman AG, Sharpe JA. Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus. A double blinded trial of three intravenous drugs. Am Neurol 1994; 35: 319-325.
2. Leigh RJ, Burnstine TH, Ruff RL, Kasmer RJ. The effect of anticholinergic drugs on upbeat and downbeat nystagmus. A double-blind study of trihexyphenidyl and trihexethyl chloride. Neurology 1991; 41: 1737-1741.
3. Arnold DB. Nystagmus induced by pharmacological inactivation of the brainstem ocular motor integrator in monkeys. Vision Res 1999; 39: 4286-4295.
4. Dieterich M, Straube A, Brandt TH, Paulus W, Buttner U. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry 1991; 54: 627-632.
5. Currie JN, Matsuo V. The use of clonazepam in treatment of nystagmus-induced oscillopsia. Ophthalmology 1986; 93: 924-932.
6. Lefkowitz D, Harpold G. Treatment of ocular myoclonus with valproic acid. Ann Neurol 1985; 17: 103-104.
7. Avebuch-Helleer L, Tusa RJ, Fuhry L, Rottach KG, Ganser GL, Heide W et al. A double blind controlled study of gabapentin and baclofen as treatment of acquired nystagmus. Ann Neurol 1997; 41: 818-825.
8. Taylor CP. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994; 44(Suppl 5): S10-s16.
9. Jain S, Proudlock F, Constantinescu C, Gottlob I. Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis. Am J Ophthalmol 2002; 134: 780-782.
10. Shery T, Proudlock FA, Sarvananthan N, McLean RJ, Gottlob I. The effects of gabapentin and memantine in acquired and congenital nystagmus - a retrospective study. Br J Ophthalmol 2006 [E-pub ahead of print].
11. Bandini E, Castello E, Mazzacca L, Mancardi GL, Solaro C. Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: How valid is the GABAergic hypothesis. J Neurol Neurosurg Psychiatry 2001; 71(1): 107-110.
12. Ronald J. Tusa. Semin Ophthalmol 1999; 14(2): 65-73.
13. Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U et al. Treatment of downbeat nystagmus with 3, 4-diaminopyridine: A placebo-controlled study. Neurology 2003; 61(2): 158-159.
14. Ruben ST, Lee JP, O'Neill DO, Dunlop I, Elston JS. The use of botulinum toxin for treatment of acquired nystagmus and oscillopsia. Ophthalmology 1994; 101: 783-787.
15. Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin. Arch Ophthalmol 1994; 112: 1320-1324.